AzTrials
AzTrials

Thoracic AnesthesiaPOWEROLNCT07353788

Mechanical Power in One-lung Ventilation

An observational study of Thoracic Anesthesia and Thoracotomy Surgery, run by Ankara University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Thoracic surgery usually necessitates one-lung ventilation (OLV) to provide surgical access while maintaining adequate gas exchange. However, OLV is associated with an increased risk of PPCs , a major cause of morbidity and mortality. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Thoracic Anesthesia, Thoracotomy Surgery
How many people
300 participants
Where
No sites listed yet
Study dates
1 Feb 2026to 1 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: hospital

Who may be able to join

  • Patients aged 18 years or older,
  • ASA physical status I-IV
  • All thoracic surgeries
  • One lung ventilation period >1 hour
  • Patients capable of giving written informed consent

Who cannot join

  • 1-Patients undergoing cardiac surgery

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

CIGDEM YILDIRIM GUCLU, Prof Dr contact

+905324576648

drcigdemyldrm@yahoo.com.tr

About this study

Official title: Postoperative Complications and Outcomes Related to Mechanical Power in One-lung Ventilation- A Multicentre Observational Study

Thoracic surgery usually necessitates one-lung ventilation (OLV) to provide surgical access while maintaining adequate gas exchange. However, OLV is associated with an increased risk of PPCs , a major cause of morbidity and mortality. Mechanical power, a composite parameter incorporating tidal volume, respiratory rate, driving pressure, and flow resistance, has been proposed as a key factor influencing ventilator-induced lung injury (VILI) and postoperative outcome. Understanding the association between mechanical power during OLV and PPCs could provide insights for optimizing intraoperative ventilatory strategies and reducing the burden of PPCs. As OLV inherently alters normal lung mechanics by decreasing functional residual capacity and introducing inequalities in ventilation-perfusion ratio, the complexity of managing mechanical power becomes even more pronounced. Under these altered conditions, the risk of PPC-including atelectasis, pneumonia, and respiratory failure-can be significantly elevated. Factors such as ventilatory settings, lung protection strategies, and the duration of OLV play pivotal roles in influencing mechanical power delivery and thereby impacting lung function recovery post-surgery. Current literature indicates a correlation between inappropriate mechanical ventilation strategies during OLV and increased incidence of PPCs. However, there remains a gap in understanding how precisely mechanical power, as a quantifiable measure, influences patient outcomes following OLV. Therefore, this study aims to investigate the relationship between mechanical power during OLV and the subsequent risk of PPC. By elucidating these dynamics, the findings may inform clinical practices surrounding OLV management, ultimately improving patient safety and outcomes in thoracic surgery.

Keywords
one lung ventilation, mechanical power, postoperative pulmonary complications

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of PPCs during the first five postoperative days, defined according to standard criteria

    Postoperative pulmonary complications ;(e.g., pneumonia, acute respiratory distress syndrome [ARDS], or prolonged mechanical ventilation).According to StEP-COMPAC group definition [Abbott et al. 2018 Br J Anaesth 2018 May;120(5):1066-1079.]

    Measured: From enrollment to the end of postoperative 5 th day

Secondary outcomes (5)
  1. Threshold mechanical power (J/min)associated with PPCs

    Measured: From enrollment to postoperative 5 th day

  2. Unscheduled ICU admission rates

    Measured: From enrollment to postoperative 5 th day

  3. Extra-pulmonary postoperative complications(number of complications)

    Measured: From enrollment to postoperative 5 th day

  4. Length of ICU stay(day)

    Measured: up to 5 th day

  5. Length of hospital stay(day)

    Measured: From enrollment to postoperative 5 th day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2026
  2. Study start1 Feb 2026 (estimated)
  3. Primary completion1 Dec 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07353788
Sponsor's protocol ID
15.10.2025
Acronym
POWEROL
Status last verified
Oct 2025
First submitted
9 Dec 2025
Last updated
20 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Thoracic Anesthesia and Thoracotomy Surgery, run by Ankara University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact CIGDEM YILDIRIM GUCLU, Prof Dr (+905324576648, drcigdemyldrm@yahoo.com.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of PPCs during the first five postoperative days, defined according to standard criteria (time frame: From enrollment to the end of postoperative 5 th day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in